Industry: Pharmaceuticals, Biotechnology
Biovest International, Inc. is a pioneer in the development of advanced individualized immunotherapies for life-threatening cancers of the blood system. Biovest is a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (NASDAQ: ABPI), with its remaining shares publicly traded. Biovest has a foundation in the manufacture of biologics for research and clinical trials. In addition, Biovest develops, manufactures and markets patented cell culture systems, including the innovative AutovaxID(TM), which is being developed as an automated vaccine manufacturing instrument and for production of cell-based materials and ( www.biovest.com )
Biovest International , Inc.
8500 Evergreen Blvd. NW
Minneapolis, Minnesota 55433
USA
Tel: (763) 786-0302
Fax: (763) 786-0915